Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-10

Clinical Trial Update: Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis [NA]

View source ↗

Summary

A clinical trial evaluating a leucine-enriched essential amino acid mixture to reverse muscle loss in cirrhosis of the liver. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leucine Enriched Essential Amino Acid Mixture (Leucine-enriched essential amino acid mixture)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Cirrhosis, Liver | NA | Status: RECRUITING